Codes / ICD10CM / M1A.479

M1A.479 Other secondary chronic gout, unspecified ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout, Unspecified Ankle and Foot

Summary

Other secondary chronic gout, unspecified ankle and foot is a form of arthritis affecting the ankle and foot joints, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages can involve the formation of tophi (urate crystal deposits) in the ankle and foot areas.

Causes

Other secondary chronic gout, unspecified ankle and foot arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the ankle and foot joints and surrounding tissues, triggering inflammation.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense ankle or foot pain, often with swelling
  • Joint stiffness and limited range of motion
  • Redness and warmth around affected joints
  • Formation of tophi (hard, painless nodules) in advanced cases

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may confirm the presence of urate crystals. Blood tests to measure uric acid levels and assess kidney function are typically performed. Imaging studies, such as X-rays or ultrasound, can help identify joint damage or tophi. The underlying cause of secondary gout is investigated through additional tests or medical history review.

Treatment Options

Treatment focuses on managing symptoms, reducing uric acid levels, and addressing the underlying condition. Acute flares may be treated with anti-inflammatory medications (e.g., NSAIDs, colchicine) or corticosteroids. Long-term management includes urate-lowering therapies (e.g., allopurinol, febuxostat) and lifestyle modifications. Underlying conditions contributing to gout are managed accordingly.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is important to monitor uric acid levels, adjust medications, and assess for complications. Untreated or poorly managed gout can lead to chronic joint damage, deformity, or tophi formation.

Complications

  • Chronic joint damage or deformity
  • Development of tophi, which may cause pain or functional impairment
  • Kidney stones or renal impairment due to uric acid accumulation
  • Increased risk of cardiovascular disease in some cases

Lifestyle & Prevention

  • Maintain a healthy weight and balanced diet low in purines (e.g., limit red meat, seafood)
  • Stay hydrated to support kidney function
  • Limit alcohol consumption, especially beer and spirits
  • Avoid medications that may elevate uric acid levels when possible
  • Follow prescribed treatment plans for underlying conditions

When to Seek Professional Help

Seek medical attention if you experience severe joint pain, swelling, or redness, especially if symptoms are recurrent or worsening. Prompt evaluation is important for accurate diagnosis and to prevent long-term complications.

Tips for Medical Coders

Document the specific location (unspecified ankle and foot) and confirm the underlying cause of secondary gout. Ensure clinical documentation supports the diagnosis and distinguishes it from primary gout or other arthritic conditions. Verify that the code aligns with the patient’s clinical presentation and any associated underlying disorders.

Book a walkthrough

M1A.479 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.